The influence of the drug Prostex on indices of erectile function in patients with symptomatic benign prostatic hyperplasia
Keywords:benign prostatic hyperplasia, erectile dysfunction, lower urinary tract symptoms, treatment, prosteks, rectal suppositories, extract prostate bulls, pumpkin seed oil
The objective: to evaluate the effect of the drug on Prosteks indicators characterizing the severity of LUTS (IPSS, QoL) and erectile dysfunction (MIEF5, hardness of erection), in sexual active patients with symptomatic BPH.
Patients and methods. In an open study of 30 sexually active patients with symptomatic BPH aged 45–55 years examined the efficacy and tolerability of Prosteks (1 rectal suppository at night for 30 days). The main performance indicators: IPSS, QoL, MIEF5, hardness of erection, minor: Qmax, PVR.
Results. It was found 30 days course Prosteks sexual active patients with symptomatic BPH and ED statistically and clinically significant effect on the total score of IPSS, QoL, total score MIEF5, Ball erection hardness. Prosteks effective in patients with mild to moderate urinary disorders caused by BPH, confirmed by a decrease in the proportion of patients with a moderate degree of impairment in its reception from 90% to 53.3%. Prosteks improves erectile function, as manifested lessening the severity of ED and increased the proportion of patients (50%), which evaluate the rigidity of erection as the maximum. Application Prosteks within 1 month does not affect the residual urine volume, prostate and PSA, and the effect of increasing Qmax has no clinical significance.
Conclusions. The results of the study give reason to recommend Prosteks for the treatment of patients with symptomatic BPH and ED with mild to moderate symptoms. Further studies are needed to determine the mechanisms underlying the clinical effects Prosteks, and whether it should be combined with uroselective alpha-blockers in severe bladder outlet obstruction.
Горпинченко И. И.. Эректильная дисфункция: диагностика и современные методы лечения // Здоровье мужчины. – No 1, 2002. – С. 9–11.
Chen Y., Yu W., Zhou L., Wu S., Yang Y., Wang J., Tian Y., He D., Xu Y., Huang J., Wang X., Gao X., Li H., Ma L., Zhang N., Zhao S., Jin X. Relationship among diet habit and lower urinary tract symptoms and sexual function in outpatient-based males with LUTS/BPH: a multiregional and cross-sectional study in China.//BMJ Open. 2016 Aug 31;6(8).
Lee J.H., Kwon H., Park YW. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship. Urology. 2013 Nov; 82(5):1008–12.
Lopatkin N.A., Kamalov A.A., Mazo E.B., Dorofeev S.D., Efremov E.A., Kozdoba A.S., Popov S.V., Mel’nik IaI, Okhobotov D.A. Administration of oral vitaprost for prevention of exacerbations of chronic abacterial prostatitis //Urologiia. – 2009 Jan(Feb;(1):29–35.
Kamalov AA, Efremov EA, Dorofeev SD, Paniushkin SM. Use of oral vitaprost in the treatment of chronic abacterial prostatitis //Urologiia. 2006 Sep(Oct;(5):45–50.
Davidov MI. Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis // Urologiia. 2011 Jan-Feb;(1):21–8.
Tkachuk VN, Tkachuk IN. Vitaprost forte efficacy in patients with prostatic adenoma // Urologiia. 2008 Jul-Aug;(4):34–7.
Ejike CE, Ezeanyika LU. Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds. //Urol Int. 2011;87(2):218–24.
Zhang X, Ouyang JZ, Zhang YS, Tayalla B, Zhou XC, Zhou SW. Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: an experimental study.// J Tongji Med Univ. 1994; 14(4):235–8.
Nishimura M., Ohkawara T., Sato H., Takeda H., Nishihira J. Pumpkin Seed Oil Extracted From Cucurbita maxima Improves Urinary Disorder in Human Overactive Bladder. J Tradit Complement Med. 2014 Jan;4(1):72–4.
Гланц С. Медико-биологическая статистика. Пер. с англ. – М.: Практика, 1998. – 459 с.
Бойко А.І., Губарь А.О. Використання препарату простекс у комплексній терапії доброякісної гіперплазії передміхурової залози //Здоровье мужчины. – 2016. – No 1 (56).
Copyright (c) 2020 І. І. Горпинченко, А. М. Ситенко
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The journal does not require authors of original (primary) research papers to assign the copyright of their published contributions. Authors grant the journal an non-exclusive licence CC BY 4.0 (Creative Commons Attribution 4.0 International License) to using and the first publication of the original in this journal. Copyright of the manuscripts is retained by the authors, after publication authors retain rights to reuse their papers in their future printed work without first requiring permission from the publisher of the journal and share their own published articles.
The journal supports the self-archiving process. Prior to publication in the journal, authors may post a copy of their manuscript in preparation or submitted to the journal in recognized non-commercial preprint servers, public websites. Authors also are encouraged to archive their final author version of the manuscript in their institution's repositories and, if they wish, on their personal websites. Authors should cite the publication reference and DOI number on the first page of any deposited version, and provide a link from it to the URL of the published article on the journal's website.
To facilitate self-archiving of original research papers and help authors fulfil funder and institutional mandates, the journal deposits manuscripts in National Library of Ukraine by V.I. Vernadsky, Scientific periodicals of Ukraine database and different international scintificd database on behalf of authors who opt-in to this free service during submission. The journal provides depositing of articles on official website of the publisher. The full text access to published papers is free.